Free Trial

Assembly Biosciences (ASMB) SEC Filings & 10K Form

Assembly Biosciences logo
$25.44 +0.48 (+1.92%)
Closing price 04:00 PM Eastern
Extended Trading
$25.54 +0.09 (+0.37%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Assembly Biosciences SEC Filings

DateFilerForm TypeView
08/12/2025
4:29 PM
Assembly Biosciences (Subject)
Schornstein Alexander (Filed by)
Form SCHEDULE 13G
08/12/2025
3:30 PM
Assembly Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
Form SCHEDULE 13D/A
08/11/2025
4:25 PM
Assembly Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025
6:02 AM
Assembly Biosciences (Filer)
Form 424B5
08/11/2025
5:05 AM
Assembly Biosciences (Filer)
Form 424B5
08/08/2025
7:24 AM
Assembly Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
8:42 PM
Assembly Biosciences (Filer)
Form S-3MEF
06/25/2025
3:05 PM
Assembly Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:10 PM
Assembly Biosciences (Filer)
Form DEF 14A
04/23/2025
3:18 PM
Assembly Biosciences (Filer)
Form DEFA14A
04/23/2025
3:05 PM
Assembly Biosciences (Filer)
Form ARS
04/15/2025
4:30 PM
Assembly Biosciences (Issuer)
McHutchison John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
11:15 PM
Assembly Biosciences (Filer)
Form EFFECT
03/20/2025
3:48 PM
Assembly Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:10 PM
Assembly Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:24 PM
Assembly Biosciences (Issuer)
Houghton Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
7:25 AM
Assembly Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
7:17 PM
Assembly Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
Form SCHEDULE 13D/A
12/23/2024
7:26 PM
Assembly Biosciences (Issuer)
GILEAD SCIENCES, INC. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:34 PM
Assembly Biosciences (Subject)
Schornstein Alexander (Filed by)
Form SCHEDULE 13G/A
12/23/2024
10:59 AM
Assembly Biosciences (Subject)
Schornstein Alexander (Filed by)
Form SCHEDULE 13G
12/19/2024
7:05 AM
Assembly Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
8:15 AM
Assembly Biosciences (Issuer)
Schornstein Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
2:22 PM
ARMISTICE CAPITAL, LLC (Filed by)
Assembly Biosciences (Subject)
Form SC 13G
11/07/2024
3:42 PM
Assembly Biosciences (Filer)
Form 424B5
11/07/2024
3:50 PM
Assembly Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
3:24 PM
Assembly Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/09/2024
8:15 AM
Assembly Biosciences (Issuer)
Schornstein Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:05 PM
Assembly Biosciences (Issuer)
Okazaki Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:05 PM
Assembly Biosciences (Issuer)
White Nicole S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
7:05 AM
Assembly Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ASMB) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners